Century Therapeutics, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
IPSC on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
25 N 38 Th Street, 11 Th Floor, Philadelphia, PA

Insiders trading volume in the past year

Century Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bayer Aktiengesellschaft 10%+ Owner $18.9M Jun 22, 2021
Versant Venture Capital VI, L.P. 10%+ Owner $18.1M Aug 9, 2022
FUJIFILM Cellular Dynamics, Inc. 10%+ Owner $10.4M Jun 22, 2021
Eli Casdin Director $4.78M Jun 9, 2022
Hyam Levitsky President of R&D $2.88M Mar 7, 2024
Brent Pfeiffenberger President and CEO, Director $1.05M -$28.6K -2.64% Mar 10, 2025
Luis Borges Chief Scientific Officer $382K Apr 3, 2023
Michael Diem Chief Financial Officer $378K Nov 1, 2023
Gregory Russotti Title: Chief Technology and Manufacturing Officer $298K -$67.2K -18.4% Mar 10, 2025
Douglas Carr SVP Finance & Operations $253K -$2.71K -1.06% Mar 10, 2025
Adrienne Farid Chief Operations Officer $155K -$8.34K -5.11% Mar 10, 2025
Chad Cowan Chief Scientific Officer $148K Mar 11, 2025
Conn Morgan Chief Finanical Officer $49K Mar 11, 2025
Daphne Quimi Director $7.66K +$7.66K Sep 12, 2024
Cynthia M. Butitta Director Jun 20, 2024
Timothy P. Walbert Director Jun 20, 2024
Osvaldo Flores Chief Executive Officer Feb 2, 2023
Rizzuto Carlo Director Jun 20, 2024
Kimberly Blackwell Director Jun 20, 2024
Joseph Jimenez Director Jun 20, 2024
Alessandro Riva Director Jun 20, 2024

Recent Insider Transactions by Companies or Individuals for Century Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.